Cargando…

Development of (68)Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET

[Image: see text] Targeted delivery of diagnostics and therapeutics offers essential advantages over nontargeted systemic delivery. These include the reduction of toxicity, the ability to reach sites beyond biological barriers, and the delivery of higher cargo concentrations to diseased sites. Virus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambidis, Elisavet, Chen, Chun-Chieh, Baikoghli, Mo, Imlimthan, Surachet, Khng, You Cheng, Sarparanta, Mirkka, Cheng, R. Holland, Airaksinen, Anu J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346612/ https://www.ncbi.nlm.nih.gov/pubmed/35857429 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00359

Ejemplares similares

Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
por: Lumen, Dave, et al.
Publicado: (2019)

Evaluation of Organo [(18)F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers
por: Otaru, Sofia, et al.
Publicado: (2020)

Development of [(18)F]AmBF(3) Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [(18)F]AmBF(3)-PEG(7)-Tyr(3)-Octreotide in an AR42J Pancreatic Carcinoma Model
por: Otaru, Sofia, et al.
Publicado: (2022)

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [(89)Zr]Zr-DFO-PEG(5)-Tz
por: Lumen, Dave, et al.
Publicado: (2022)

Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity
por: Sokka, Iris K., et al.
Publicado: (2021)

Metabolism of a Bioorthogonal PET Tracer Candidate [(19)F/(18)F]SiFA-Tetrazine in Mouse Liver Microsomes: Biotransformation Pathways and Defluorination Investigated by UHPLC-HRMS
por: Otaru, Sofia, et al.
Publicado: (2020)

Translational assessment of a DATA-functionalized FAP inhibitor with facile (68)Ga-labeling at room temperature
por: Escudero-Castellanos, Alondra, et al.
Publicado: (2023)

Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with $^{155}$Tb
por: Jakobsson, Ulrika, et al.
Publicado: (2020)

Sweet Battle of the Epimers—Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy
por: Matović, Jelena, et al.
Publicado: (2023)

Addressing the Biochemical Foundations of a Glucose-Based “Trojan Horse”-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment
por: Matović, Jelena, et al.
Publicado: (2020)

Highly variable biodistribution of (68)Ga labeled somatostatin analogues (68)Ga-DOTA-NOC and (68)Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
por: Cheng, Monica, et al.
Publicado: (2022)

Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies
por: Vatsa, Rakhee, et al.
Publicado: (2018)

PET imaging of PARP expression using (68)Ga-labelled inhibitors
por: Wang, Xiangwei, et al.
Publicado: (2023)

Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter
por: Matović, Jelena, et al.
Publicado: (2022)

SPECT/CT Imaging of hNIS -Expression after Intravenous Delivery of an Oncolytic Adenovirus and (131)I
por: Rajecki, Maria, et al.
Publicado: (2012)

Development of (68)Ga-labelled ultrasound microbubbles for whole-body PET imaging
por: Hernández-Gil, Javier, et al.
Publicado: (2019)

A Comparative (68)Ga-Citrate and (68)Ga-Chloride PET/CT Imaging of Staphylococcus aureus Osteomyelitis in the Rat Tibia
por: Lankinen, Petteri, et al.
Publicado: (2018)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

Radiolabelling of peptides with tetrazine ligation based on the inverse electron-demand Diels–Alder reaction: rapid, catalyst-free and mild conversion of 1,4-dihydropyridazines to pyridazines
por: Otaru, Sofia, et al.
Publicado: (2023)

Peptide-Based [(68)Ga]Ga Labeled PET Tracer for Tumor Imaging by Targeting Tumor-Associated Macrophages
por: Huang, Mingxing, et al.
Publicado: (2022)

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010)

PET Imaging of FSHR Expression in Tumors with (68)Ga-Labeled FSH1 Peptide
por: Pan, Donghui, et al.
Publicado: (2017)

pH-Responsive Carboxymethylcellulose Nanoparticles for (68)Ga-WBC Labeling in PET Imaging
por: Piras, Anna Maria, et al.
Publicado: (2019)

Recent Advances of (68)Ga-Labeled PET Radiotracers with Nitroimidazole in the Diagnosis of Hypoxia Tumors
por: Nguyen, Anh Thu, et al.
Publicado: (2023)

Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles
por: Keinänen, Outi, et al.
Publicado: (2017)

ImmunoPET imaging of human CD8(+) T cells with novel (68)Ga-labeled nanobody companion diagnostic agents
por: Zhao, Haitao, et al.
Publicado: (2021)

[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021)

Synthesis of (68)Ga-Labeled cNGR-Based Glycopeptides and In Vivo Evaluation by PET Imaging
por: Gyuricza, Barbara, et al.
Publicado: (2021)

Optimized (68)Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer
por: Wu, Yitian, et al.
Publicado: (2022)

(68)Ga-labeled amphiphilic polymer nanoparticles for PET imaging of sentinel lymph node metastasis
por: Chen, Qin, et al.
Publicado: (2023)

Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020)

Accuracy of PET quantification in [(68)Ga]Ga-pentixafor PET/MR imaging of carotid plaques
por: Rausch, Ivo, et al.
Publicado: (2020)

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2013)

Localization of Pyelonephritis by (68)Ga-FAPI PET CT
por: Jagtap, Rajlaxmi Rangrao, et al.
Publicado: (2023)

Musculoskeletal pitfalls in (68)Ga-PSMA PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023)

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2014)

Diagnostic challenges in a patient with an occult insulinoma:(68 )Ga‐DOTA‐exendin‐4 PET/CT and (68)Ga‐DOTATATE PET/CT
por: Bongetti, Elisa, et al.
Publicado: (2018)

(68)Ga-Labeled Cyclic NGR Peptide for MicroPET Imaging of CD13 Receptor Expression
por: Shao, Yahui, et al.
Publicado: (2014)

Preclinical Melanoma Imaging with (68)Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET
por: Zhang, Chengcheng, et al.
Publicado: (2017)

(68)Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
por: Baudhuin, Henri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fr57s6vk77h5jdptht6gjfvji0